|
COPYRIGHT 2002 PR Newswire Association LLC
Chromos Molecular Systems Inc. ("CHROMOS"; TSX: CHR), a global leader in the development and commercialization of chromosome-based technologies, today announced Third Quarter financial results for the period ended September 30, 2002.
"Chromos' achievements for this past quarter reflect our previously announced transition to a biopharmaceutical focus", said Alistair Duncan, President and CEO of Chromos. "As we enter our last quarter of the year, we have already achieved 6 of our 8 corporate milestones, most recently the establishment of a corporate partnership with a leading contract protein manufacturer. We will continue to demonstrate further progress with our research and...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
